semaglutide and hfpef in Patients With Obesity Heart Failure Across Mildly Reduced or Preserved Ejection Fraction Semaglutide and NT-proBNP in Obesity-Related

In the UK, the MHRA oversees the safety of medicines in clinical trials

Over 12 days of treatment, LIRA reduced body weight, food intake and fat mass, similarly in Gipr AP-KO and control Gipr AP-GFP mice, compared with VEH control-injected groups (Fig

The adverse health effects of cannabis use: what are they, and what are their implications for policy

Obesity is known to induce systemic inflammation and atrial remodeling, which are key drivers of AF

106 (1), e11e19 (2021)

We also offer many other peptide treatments, including Sermorelin for lean muscle mass and fat loss, PT-141 for sexual enhancement, and Selank for anti-anxiety and stress reduction